Ninth Circuit Decision Makes it Harder for Plaintiffs to Plead Securities Fraud Claims Against Drug & Medical Device Companies

Stradling Yocca Carlson & Rauth
Contact

On June 10, 2020, the Ninth Circuit, in Vicky Nguyen v. Endologix, Inc., et al., affirmed in a published decision the district court’s dismissal with prejudice of a putative securities fraud class action because plaintiff failed to meet the heightened pleading standard for scienter required under the Private Securities Litigation Reform Act of 1995 (“PSLRA”). On July 20, 2020, the Ninth Circuit denied plaintiff’s petition for rehearing. A Stradling team lead by Jason de Bretteville represented defendants-appellees in the case.

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Stradling Yocca Carlson & Rauth | Attorney Advertising

Written by:

Stradling Yocca Carlson & Rauth
Contact
more
less

Stradling Yocca Carlson & Rauth on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.